EPO Patents = 3

Trademarks = 2

Forward Citations = 27

Loading Chart...

14 inventors (with patents filed for the assignee):

Wenge Zhong (8 out of 46 patents)

Wei Guo (3 out of 36 patents)

Zhilong Hu (2 out of 7 patents)

4. Fei Zhang (2 out of 15 patents)

5. Wei Huang (1 out of 75 patents)

6. Fei Xiao (1 out of 3 patents)

7. Xiawei Jiang (1 out of 3 patents)

8. Xiaotian Zhu (1 out of 39 patents)

9. Hu He (1 out of 10 patents)

10. Meng Jiang (1 out of 2 patents)

11. Xudong Wei (1 out of 1 patent)

12. Beibei Chen (1 out of 1 patent)

13. Teng Feng (1 out of 1 patent)

14. Kailiang Wang (1 out of 1 patent)

15. Zheng Jane Li (1 out of 2 patents)

8 patents: Sort by Forward Citations

1. 12760007 - Salt and crystal forms of GLP-1R agonists and uses thereof (2026-10-13),

2. 12708623 - CDK INHIBITORS (2026-08-18),

3. 12692263 - SOS1 inhibitors and uses thereof (2026-07-28),

4. 12516041 - Crystal forms of GLP-1R agonists and uses thereof (2026-01-06),

5. 12365670 - GLP-IR agonists and uses thereof (2025-07-22),

6. 11591321 - GLP-1R agonists and uses thereof (2023-02-28),

7. 10954221 - GLP-1R agonists and uses thereof (2021-03-23),

8. 10844049 - GLP-1R agonists and uses thereof (2020-11-24),

Company Overview

Qilu Regor Therapeutics Inc. is a biopharmaceutical company focused on the discovery and development of innovative therapies for cancer and other serious diseases. The company leverages advanced technologies and a strong scientific foundation to create targeted treatments that aim to improve patient outcomes. With a commitment to research and development, Qilu Regor Therapeutics is dedicated to addressing unmet medical needs and advancing the field of oncology. Their pipeline includes several promising candidates that are currently in various stages of clinical trials, reflecting their mission to bring new hope to patients worldwide.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

8 Patents

#307 in Shanghai

#3,471 in China

Shanghai, China

Qilu Regor Therapeutics Inc.

Forward Citations = 27

14 inventors:

Wenge Zhong (8 out of 46 patents)

Wei Guo (3 out of 36 patents)

Zhilong Hu (2 out of 7 patents)

4. Fei Zhang (2 out of 15 patents)

5. Wei Huang (1 out of 75 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Qilu Regor Therapeutics Inc.. Retrieved from https://idiyas.com/company/qilu-regor-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]